Advances in Spine Oncology 2.0

Dear Colleagues,

Tumors affecting the spine are a challenging pathologic entity that requires the collaboration of multiple medical specialties. The life expectancy of patients affected by tumors of the spine (primary or metastatic) has increased considerably. This is principally due to advances in the field of oncologic therapies and surgical solutions.

Molecular targeted therapy is changing the way we treat cancer. Knowing the molecular signature of a specific tumor can lead to targeted therapy and improved outcomes.

In parallel, the use of spinal surgery has increased considerably worldwide over the last 30 years, leading to the development of new, often minimally invasive, surgical approaches and techniques. Tremendous advances have been made in the field of biomaterials, for example, new carbon fiber implants, 3D-printed prosthesis, or “vertebral transplant” for reconstruction after the resection of tumors from the spine.

This Special Issue will accept articles on molecular research and molecular mechanisms concerning the pathophysiology of spine tumors, molecular and biological therapies, particle therapy, radiation therapy, radiation oncology, new materials, nanoparticles, and interventional radiology. Both basic science articles and reviews are welcome. The issue aims to put together the advances reached in a field which is as multidisciplinary as spine oncology.

Dr. Alessandro Gasbarrini
Dr. Cristiana Griffoni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.